Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/29299
DC FieldValueLanguage
dc.contributor.authorQuezada, Andrésen_US
dc.contributor.authorJiménez, Daviden_US
dc.contributor.authorBikdeli, Behnooden_US
dc.contributor.authorMuriel, Alfonsoen_US
dc.contributor.authorAramberri, Marioen_US
dc.contributor.authorLópez-Jiménez, Lucianoen_US
dc.contributor.authorSahuquillo, Joan Carlesen_US
dc.contributor.authorOtero, Remediosen_US
dc.contributor.authorPorfidia, Angeloen_US
dc.contributor.authorMonreal, Manuelen_US
dc.contributor.authorRIETE Investigatorsen_US
dc.contributor.authorBosevski, Marijanen_US
dc.contributor.authorZdraveska, Marijaen_US
dc.date.accessioned2024-02-13T12:37:15Z-
dc.date.available2024-02-13T12:37:15Z-
dc.date.issued2020-07-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/29299-
dc.description.abstract The association between the use of inferior vena cava filters (IVCFs) and outcomes among patients with cancer-associated thromboembolism (CT) and contraindications to anticoagulation remains unclear.en_US
dc.language.isoenen_US
dc.publisherGeorg Thieme Verlag KGen_US
dc.relation.ispartofThrombosis and Haemostasisen_US
dc.titleOutcomes after Vena Cava Filter Use in Patients with Cancer-Associated Venous Thromboembolism and Contraindications to Anticoagulationen_US
dc.typeArticleen_US
dc.identifier.doi10.1055/s-0040-1710589-
dc.identifier.urlhttp://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0040-1710589.pdf-
dc.identifier.volume120-
dc.identifier.issue7-
dc.identifier.fpage1035-
dc.identifier.lpage1044-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Прикажи едноставен запис

Page view(s)

16
checked on 16.5.2024

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.